Ir al contenido
· Rellenos dérmicos
SKU 11053 · GTIN 4046222005146

Radiesse (+) Lidocaine

En stock
Volumen
1 x 1,5 mL
Laboratorio
Merz Aesthetics
Origen
Estados Unidos
Indicación
Moderate to deep facial folds, facial volume loss
El precio profesional y su historial son solo para cuentas verificadas
allpara suministra a profesionales autorizados. Inicie sesión o solicite una cuenta B2B para ver los precios en tiempo real, los tramos por volumen y el historial de precios.

Radiesse (+) Lidocaine is a sterile, latex-free, non-pyrogenic, semi-solid cohesive injectable implant manufactured by Merz Aesthetics, developed for deep dermal and sub-dermal soft tissue augmentation. It suits supraperiosteal, sub-dermal and deep dermal placement with a 27G needle, and deep blunt-tip cannula injection for the jawline. It is 30% synthetic CaHA particles (25 to 45 microns) in a 70% gel carrier with 0.3% lidocaine hydrochloride; the carrier dissipates in vivo while the CaHA remains, for long-term but non-permanent augmentation. One 1.5 mL pre-filled syringe and two 27G thin-wall needles come sterile in a sealed foil pouch, for single treatment use.

Principales ventajas de Radiesse (+) Lidocaine

  • Synthetic calcium hydroxylapatite implant with 0.3% lidocaine hydrochloride included for a short-term local anaesthetic effect during injection
  • 30% CaHA particles and 70% gel carrier by volume, with a particle size of 25 to 45 microns
  • The gel carrier is dissipated in vivo and replaced with soft tissue growth, while the CaHA remains at the injection site
  • Indicated for the jawline and marionette lines in addition to nasolabial folds, cheeks and the dorsum of the hands
  • A lifetime of at least 12 months for cheek augmentation, the jawline and hand augmentation, as demonstrated minimums rather than expected end points
  • Well suited to supraperiosteal, sub-dermal and deep dermal placement; jawline placement by blunt-tip cannula has been clinically evaluated
  • Supplied sterile in a sealed foil pouch as one 1.5 mL syringe with two 27G thin-wall needles
  • CE marked under EU MDR 2017/745 via notified body 0123, supplied with a patient Implant Card
  • Manufactured by Merz Aesthetics in the USA
Información clave
Marca RADIESSE
Fabricante Merz Aesthetics
País de origen United States
Certificación CE 0123
Composición Synthetic calcium hydroxylapatite (CaHA) particles, 25-45 microns, suspended in a gel carrier of sterile water for injection, glycerin, sodium carboxymethylcellulose and 0.3% lidocaine hydrochloride (w/v), buffered with sodium phosphate salts. By volume 30% CaHA particles and 70% gel carrier; by weight CaHA 55.6-56.5%, sterile water 35.4-36.2%, glycerin 6.3-6.5%, sodium carboxymethylcellulose 1.06-1.36%, phosphates 0.30-0.31% and lidocaine HCl monohydrate 0.22-0.23%. Non-animal-based and free from animal protein
Volumen / Tamaño 1.5 ml
Envase One pre-filled 1.5 mL syringe with a Terumo K-Pack II containing two 27G thin-wall injection needles, supplied sterile in a sealed foil pouch. Single person, single treatment use
Tamaño de la aguja 27G thin-wall needle with a standard Luer fitting; two needles supplied in the pack
Tipo de uso For professional use - qualified practitioners and clinics only
Profundidad de inyección Deep dermal and sub-dermal soft tissue augmentation. Highly viscoelastic CaHA is well suited to supraperiosteal, sub-dermal and deep dermal placement. For the jawline, deep injection by blunt-tip cannula has been clinically evaluated
Protocolo / Duración A lifetime of at least a year or more in most persons across most approved indications: at least 12 months for cheek augmentation, the jawline and hand augmentation, and at least 6-7 months for nasolabial folds and marionette lines. These are minimum persistence figures demonstrated in clinical follow-up rather than expected end points. Duration varies with the patient, the area treated, the volume placed and the injection technique

Indicaciones y uso profesional

Indicaciones principales

  • Treatment of nasolabial folds
  • Augmentation of the cheeks
  • Treatment of marionette lines
  • Treatment of the jawline
  • Hand augmentation to correct volume loss in the dorsum of the hands

Uso profesional

Radiesse (+) Lidocaine is only to be administered by appropriately trained healthcare professionals who are qualified or accredited in accordance with national law. The product is supplied sterile and non-pyrogenic in a sealed foil pouch and is intended for single-person, single-treatment use only, for deep dermal and sub-dermal soft tissue augmentation. Because this presentation contains 0.3% lidocaine hydrochloride, practitioners must screen for known hypersensitivity to lidocaine or to anaesthetics of the amide type before use. Injection technique, plane and volume are determined by the treating practitioner on a per-patient basis. Introduction of the implant into the vasculature may lead to embolisation, occlusion of the vessels, ischaemia or infarction, so particular care is required when injecting soft tissue fillers. The product must not be re-sterilised, and must not be used if the foil pouch is compromised or the syringe damaged.

Zonas de tratamiento

  • Nasolabial folds
  • Cheeks
  • Marionette lines
  • Jawline
  • Dorsum of the hands
  • Not intended for the glabellar folds or the nose area, where a higher incidence of localised necrosis has been associated with injection

Perfil del paciente

Suitable for adult patients assessed as appropriate by the treating practitioner. Radiesse (+) Lidocaine is contraindicated in the presence of acute or chronic inflammation or infection involving the area to be treated; in persons with severe allergies manifested by a history of anaphylaxis, or a history or presence of multiple severe allergies; in persons with known hypersensitivity to any of the components; in persons with known hypersensitivity to lidocaine or to anaesthetics of the amide type; in persons prone to developing inflammatory skin conditions or with a tendency to develop hypertrophic scars and keloids; in persons with bleeding disorders; in persons under 18 years; and during pregnancy and in breastfeeding females. It must not be implanted in the epidermis or used as a skin replacement, and is not intended for correction of the glabellar folds or the nose area. For hand augmentation, the safety of injection into the dorsum of the hand has not been studied in persons under 26 or over 79 years of age, volumes over 3 mL per hand in a treatment session have not been studied, and safety beyond two years in the hand has not been investigated in clinical trials.

Cómo funciona Radiesse (+) Lidocaine ​

Radiesse (+) Lidocaine works through synthetic calcium hydroxylapatite microspheres, 25 to 45 microns in size, suspended in a gel carrier of sterile water, glycerin, sodium carboxymethylcellulose and 0.3% lidocaine hydrochloride. The gel carrier is dissipated in vivo and replaced with soft tissue growth, while the calcium hydroxylapatite remains at the site of injection, producing a long-term yet non-permanent restoration and augmentation. Highly viscoelastic CaHA is well suited to supraperiosteal, sub-dermal and deep dermal placement, where it delivers a considerable volumising effect. The lidocaine acts locally during administration to provide a short-term anaesthetic effect and does not alter this action.

Por qué comprar en Allpara

Allpara ofrece productos RADIESSE originales y verificados de proveedores seleccionados, con trazabilidad completa de lotes y asesoramiento experto. Atendemos a clínicas y profesionales de la estética con productos con certificado CE, entrega rápida en toda la UE desde nuestro almacén en la UE y precios profesionales competitivos. Nuestra prioridad es la seguridad, la satisfacción y los resultados de sus pacientes, con un servicio posventa dedicado para su tranquilidad.

Preguntas frecuentes

How does Radiesse (+) Lidocaine differ from standard Radiesse?

Radiesse (+) Lidocaine contains 0.3% lidocaine hydrochloride in the gel carrier, which provides a short-term local anaesthetic effect during administration. The indications also differ: this presentation covers marionette lines and the jawline in addition to nasolabial folds, cheeks and the dorsum of the hands.

Which areas is Radiesse (+) Lidocaine indicated for?

It is indicated for the treatment of nasolabial folds, augmentation of the cheeks, treatment of marionette lines, treatment of the jawline, and hand augmentation to correct volume loss in the dorsum of the hands. It is not intended for the glabellar folds or the nose area.

How long does Radiesse (+) Lidocaine last?

It has a lifetime of at least a year or more in most persons across most approved indications: at least 12 months for cheek augmentation, the jawline and hand augmentation, and at least 6 to 7 months for nasolabial folds and marionette lines. These are minimum persistence figures demonstrated in clinical follow-up rather than expected end points.

/ Especificaciones

La ficha técnica

Categoría
Rellenos dérmicos
Marca
RADIESSE
Laboratorio
Merz Aesthetics
SKU
11053
GTIN
4046222005146
Formato
1 x 1,5 mL
Origen
Estados Unidos
Indicación
Moderate to deep facial folds, facial volume loss
Uso
Professional use, qualified practitioners
/ Detalles del producto

El expediente completo

Radiesse (+) Lidocaine is a sterile, latex-free, non-pyrogenic, semi-solid cohesive injectable implant manufactured by Merz Aesthetics, developed for deep dermal and sub-dermal soft tissue augmentation. It suits supraperiosteal, sub-dermal and deep dermal placement with a 27G needle, and deep blunt-tip cannula injection for the jawline. It is 30% synthetic CaHA particles (25 to 45 microns) in a 70% gel carrier with 0.3% lidocaine hydrochloride; the carrier dissipates in vivo while the CaHA remains, for long-term but non-permanent augmentation. One 1.5 mL pre-filled syringe and two 27G thin-wall needles come sterile in a sealed foil pouch, for single treatment use.

Merz Aesthetics, país de origen Estados Unidos.

Enviado a toda la UE desde nuestro almacén en la UE, con seguimiento y seguro, y envío en 24-72h. Cada unidad se envía con número de lote y fecha de caducidad, en depósito aduanero de la UE y con trazabilidad de lote.

Conservar según las especificaciones del fabricante, protegido de la luz directa. La cadena de frío solo se utiliza cuando el producto lo requiere.

Condiciones de pago a 30 / 60 / 90 días* disponibles para cuentas verificadas previa aprobación de crédito. Se admite la facturación en EUR, CHF y GBP.

Las condiciones son orientativas y se confirman tras la revisión de la cuenta.

How does Radiesse (+) Lidocaine differ from standard Radiesse?

Radiesse (+) Lidocaine contains 0.3% lidocaine hydrochloride in the gel carrier, which provides a short-term local anaesthetic effect during administration. The indications also differ: this presentation covers marionette lines and the jawline in addition to nasolabial folds, cheeks and the dorsum of the hands.

Which areas is Radiesse (+) Lidocaine indicated for?

It is indicated for the treatment of nasolabial folds, augmentation of the cheeks, treatment of marionette lines, treatment of the jawline, and hand augmentation to correct volume loss in the dorsum of the hands. It is not intended for the glabellar folds or the nose area.

How long does Radiesse (+) Lidocaine last?

It has a lifetime of at least a year or more in most persons across most approved indications: at least 12 months for cheek augmentation, the jawline and hand augmentation, and at least 6 to 7 months for nasolabial folds and marionette lines. These are minimum persistence figures demonstrated in clinical follow-up rather than expected end points.

/ Respuestas rápidas

Todo lo que un comprador pregunta primero

How does Radiesse (+) Lidocaine differ from standard Radiesse?
Radiesse (+) Lidocaine contains 0.3% lidocaine hydrochloride in the gel carrier, which provides a short-term local anaesthetic effect during administration. The indications also differ: this presentation covers marionette lines and the jawline in addition to nasolabial folds, cheeks and the dorsum of the hands.
Which areas is Radiesse (+) Lidocaine indicated for?
It is indicated for the treatment of nasolabial folds, augmentation of the cheeks, treatment of marionette lines, treatment of the jawline, and hand augmentation to correct volume loss in the dorsum of the hands. It is not intended for the glabellar folds or the nose area.
How long does Radiesse (+) Lidocaine last?
It has a lifetime of at least a year or more in most persons across most approved indications: at least 12 months for cheek augmentation, the jawline and hand augmentation, and at least 6 to 7 months for nasolabial folds and marionette lines. These are minimum persistence figures demonstrated in clinical follow-up rather than expected end points.
/ FAQ

Preguntas frecuentes

Radiesse (+) Lidocaine contains 0.3% lidocaine hydrochloride in the gel carrier, which provides a short-term local anaesthetic effect during administration. The indications also differ: this presentation covers marionette lines and the jawline in addition to nasolabial folds, cheeks and the dorsum of the hands.
It is indicated for the treatment of nasolabial folds, augmentation of the cheeks, treatment of marionette lines, treatment of the jawline, and hand augmentation to correct volume loss in the dorsum of the hands. It is not intended for the glabellar folds or the nose area.
It has a lifetime of at least a year or more in most persons across most approved indications: at least 12 months for cheek augmentation, the jawline and hand augmentation, and at least 6 to 7 months for nasolabial folds and marionette lines. These are minimum persistence figures demonstrated in clinical follow-up rather than expected end points.

Más productos de Merz

Ver laboratorio

Alternativas para la clínica

Todos los productos

Radiesse (+) Lidocaine

En stock
Precios solo para cuentas verificadas
Inicie sesión o solicite una cuenta B2B para ver su precio.
Solicitar cuenta B2B

Radiesse (+) Lidocaine is a sterile, latex-free, non-pyrogenic, semi-solid cohesive injectable implant manufactured by Merz Aesthetics, developed for deep dermal and sub-dermal soft tissue augmentation. It suits supraperiosteal, sub-dermal and deep dermal placement with a 27G needle, and deep blunt-tip cannula injection for the jawline. It is 30% synthetic CaHA particles (25 to 45 microns) in a 70% gel carrier with 0.3% lidocaine hydrochloride; the carrier dissipates in vivo while the CaHA remains, for long-term but non-permanent augmentation. One 1.5 mL pre-filled syringe and two 27G thin-wall needles come sterile in a sealed foil pouch, for single treatment use.

Principales ventajas de Radiesse (+) Lidocaine

  • Synthetic calcium hydroxylapatite implant with 0.3% lidocaine hydrochloride included for a short-term local anaesthetic effect during injection
  • 30% CaHA particles and 70% gel carrier by volume, with a particle size of 25 to 45 microns
  • The gel carrier is dissipated in vivo and replaced with soft tissue growth, while the CaHA remains at the injection site
  • Indicated for the jawline and marionette lines in addition to nasolabial folds, cheeks and the dorsum of the hands
  • A lifetime of at least 12 months for cheek augmentation, the jawline and hand augmentation, as demonstrated minimums rather than expected end points
  • Well suited to supraperiosteal, sub-dermal and deep dermal placement; jawline placement by blunt-tip cannula has been clinically evaluated
  • Supplied sterile in a sealed foil pouch as one 1.5 mL syringe with two 27G thin-wall needles
  • CE marked under EU MDR 2017/745 via notified body 0123, supplied with a patient Implant Card
  • Manufactured by Merz Aesthetics in the USA
Información clave
Marca RADIESSE
Fabricante Merz Aesthetics
País de origen United States
Certificación CE 0123
Composición Synthetic calcium hydroxylapatite (CaHA) particles, 25-45 microns, suspended in a gel carrier of sterile water for injection, glycerin, sodium carboxymethylcellulose and 0.3% lidocaine hydrochloride (w/v), buffered with sodium phosphate salts. By volume 30% CaHA particles and 70% gel carrier; by weight CaHA 55.6-56.5%, sterile water 35.4-36.2%, glycerin 6.3-6.5%, sodium carboxymethylcellulose 1.06-1.36%, phosphates 0.30-0.31% and lidocaine HCl monohydrate 0.22-0.23%. Non-animal-based and free from animal protein
Volumen / Tamaño 1.5 ml
Envase One pre-filled 1.5 mL syringe with a Terumo K-Pack II containing two 27G thin-wall injection needles, supplied sterile in a sealed foil pouch. Single person, single treatment use
Tamaño de la aguja 27G thin-wall needle with a standard Luer fitting; two needles supplied in the pack
Tipo de uso For professional use - qualified practitioners and clinics only
Profundidad de inyección Deep dermal and sub-dermal soft tissue augmentation. Highly viscoelastic CaHA is well suited to supraperiosteal, sub-dermal and deep dermal placement. For the jawline, deep injection by blunt-tip cannula has been clinically evaluated
Protocolo / Duración A lifetime of at least a year or more in most persons across most approved indications: at least 12 months for cheek augmentation, the jawline and hand augmentation, and at least 6-7 months for nasolabial folds and marionette lines. These are minimum persistence figures demonstrated in clinical follow-up rather than expected end points. Duration varies with the patient, the area treated, the volume placed and the injection technique

Indicaciones y uso profesional

Indicaciones principales

  • Treatment of nasolabial folds
  • Augmentation of the cheeks
  • Treatment of marionette lines
  • Treatment of the jawline
  • Hand augmentation to correct volume loss in the dorsum of the hands

Uso profesional

Radiesse (+) Lidocaine is only to be administered by appropriately trained healthcare professionals who are qualified or accredited in accordance with national law. The product is supplied sterile and non-pyrogenic in a sealed foil pouch and is intended for single-person, single-treatment use only, for deep dermal and sub-dermal soft tissue augmentation. Because this presentation contains 0.3% lidocaine hydrochloride, practitioners must screen for known hypersensitivity to lidocaine or to anaesthetics of the amide type before use. Injection technique, plane and volume are determined by the treating practitioner on a per-patient basis. Introduction of the implant into the vasculature may lead to embolisation, occlusion of the vessels, ischaemia or infarction, so particular care is required when injecting soft tissue fillers. The product must not be re-sterilised, and must not be used if the foil pouch is compromised or the syringe damaged.

Zonas de tratamiento

  • Nasolabial folds
  • Cheeks
  • Marionette lines
  • Jawline
  • Dorsum of the hands
  • Not intended for the glabellar folds or the nose area, where a higher incidence of localised necrosis has been associated with injection

Perfil del paciente

Suitable for adult patients assessed as appropriate by the treating practitioner. Radiesse (+) Lidocaine is contraindicated in the presence of acute or chronic inflammation or infection involving the area to be treated; in persons with severe allergies manifested by a history of anaphylaxis, or a history or presence of multiple severe allergies; in persons with known hypersensitivity to any of the components; in persons with known hypersensitivity to lidocaine or to anaesthetics of the amide type; in persons prone to developing inflammatory skin conditions or with a tendency to develop hypertrophic scars and keloids; in persons with bleeding disorders; in persons under 18 years; and during pregnancy and in breastfeeding females. It must not be implanted in the epidermis or used as a skin replacement, and is not intended for correction of the glabellar folds or the nose area. For hand augmentation, the safety of injection into the dorsum of the hand has not been studied in persons under 26 or over 79 years of age, volumes over 3 mL per hand in a treatment session have not been studied, and safety beyond two years in the hand has not been investigated in clinical trials.

Cómo funciona Radiesse (+) Lidocaine ​

Radiesse (+) Lidocaine works through synthetic calcium hydroxylapatite microspheres, 25 to 45 microns in size, suspended in a gel carrier of sterile water, glycerin, sodium carboxymethylcellulose and 0.3% lidocaine hydrochloride. The gel carrier is dissipated in vivo and replaced with soft tissue growth, while the calcium hydroxylapatite remains at the site of injection, producing a long-term yet non-permanent restoration and augmentation. Highly viscoelastic CaHA is well suited to supraperiosteal, sub-dermal and deep dermal placement, where it delivers a considerable volumising effect. The lidocaine acts locally during administration to provide a short-term anaesthetic effect and does not alter this action.

Por qué comprar en Allpara

Allpara ofrece productos RADIESSE originales y verificados, con trazabilidad completa de lotes, stock con certificado CE, entrega rápida en toda la UE y servicio posventa experto.

Preguntas frecuentes

How does Radiesse (+) Lidocaine differ from standard Radiesse?

Radiesse (+) Lidocaine contains 0.3% lidocaine hydrochloride in the gel carrier, which provides a short-term local anaesthetic effect during administration. The indications also differ: this presentation covers marionette lines and the jawline in addition to nasolabial folds, cheeks and the dorsum of the hands.

Which areas is Radiesse (+) Lidocaine indicated for?

It is indicated for the treatment of nasolabial folds, augmentation of the cheeks, treatment of marionette lines, treatment of the jawline, and hand augmentation to correct volume loss in the dorsum of the hands. It is not intended for the glabellar folds or the nose area.

How long does Radiesse (+) Lidocaine last?

It has a lifetime of at least a year or more in most persons across most approved indications: at least 12 months for cheek augmentation, the jawline and hand augmentation, and at least 6 to 7 months for nasolabial folds and marionette lines. These are minimum persistence figures demonstrated in clinical follow-up rather than expected end points.

Más productos de Merz

Ver el laboratorio →

Radiesse (+) Lidocaine is a sterile, latex-free, non-pyrogenic, semi-solid cohesive injectable implant manufactured by Merz Aesthetics, developed for deep dermal and sub-dermal soft tissue augmentation. It suits supraperiosteal, sub-dermal and deep dermal placement with a 27G needle, and deep blunt-tip cannula injection for the jawline. It is 30% synthetic CaHA particles (25 to 45 microns) in a 70% gel carrier with 0.3% lidocaine hydrochloride; the carrier dissipates in vivo while the CaHA remains, for long-term but non-permanent augmentation. One 1.5 mL pre-filled syringe and two 27G thin-wall needles come sterile in a sealed foil pouch, for single treatment use.

Merz Aesthetics, país de origen Estados Unidos.

Enviado a toda la UE desde nuestro almacén en la UE, envío en 24-72h, con seguimiento y seguro. Cada unidad se envía con número de lote y fecha de caducidad, en depósito aduanero de la UE y con trazabilidad de lote. Conservar según las especificaciones del fabricante.

Pago a 30 / 60 / 90 días* para cuentas verificadas previa aprobación de crédito. Facturación en EUR, CHF y GBP.

How does Radiesse (+) Lidocaine differ from standard Radiesse?

Radiesse (+) Lidocaine contains 0.3% lidocaine hydrochloride in the gel carrier, which provides a short-term local anaesthetic effect during administration. The indications also differ: this presentation covers marionette lines and the jawline in addition to nasolabial folds, cheeks and the dorsum of the hands.

Which areas is Radiesse (+) Lidocaine indicated for?

It is indicated for the treatment of nasolabial folds, augmentation of the cheeks, treatment of marionette lines, treatment of the jawline, and hand augmentation to correct volume loss in the dorsum of the hands. It is not intended for the glabellar folds or the nose area.

How long does Radiesse (+) Lidocaine last?

It has a lifetime of at least a year or more in most persons across most approved indications: at least 12 months for cheek augmentation, the jawline and hand augmentation, and at least 6 to 7 months for nasolabial folds and marionette lines. These are minimum persistence figures demonstrated in clinical follow-up rather than expected end points.

* Producto de uso profesional. El envase puede variar según el lote o el mercado. Consulte las instrucciones de uso suministradas para las indicaciones completas y las contraindicaciones.